Showing results (191-200 of 277) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumorsAnthony W Tolcher, Wells A Messersmith, Stanislaw M Mikulski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancerMark A Socinski, Jonathan Goldman, Iman El-Hariry, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Phase IB Study of Osimertinib in Combination with Navitoclax in <i>EGFR</i>-mutant NSCLC Following Resistance to Initial <i>EGFR</i> Therapy (ETCTN 9903)Erin M Bertino, Ryan D Gentzler, Sarah Clifford, et al.Elife|November 14, 2018
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13Mei Zeng, Nicholas P Kwiatkowski, Tinghu Zhang, et al.Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumorsGeoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.Cancer Research|October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogeneZhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.Nature Communications|September 23, 2021
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancerPanagiotis A Konstantinopoulos, Alexandre André B A da Costa, Doga Gulhan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)Matthew Ingham, Jacob B Allred, Li Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 2009
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapySamanthi A Perera, Danan Li, Takeshi Shimamura, et al.Pageof 28